NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

Pegfilgrastim生物相似藥的全球市場:至2030年的機會及策略 - COVID19影響與復甦

Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Impact and Recovery

出版商 The Business Research Company 商品編碼 980101
出版日期 內容資訊 英文 206 Pages
商品交期: 2-3個工作天內
價格
Pegfilgrastim生物相似藥的全球市場:至2030年的機會及策略 - COVID19影響與復甦 Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Impact and Recovery
出版日期: 2020年12月28日內容資訊: 英文 206 Pages
簡介

本報告提供全球Pegfilgrastim生物相似藥市場的相關調查,市場規模和預測,趨勢和策略,成長及阻礙因素,COVID-19的影響,各用途、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 目錄

第3章 圖的清單

第4章 表格的清單

第5章 報告結構

第6章 簡介

    • 各地區市場區隔
    • 各用途市場區隔
    • 各流通管道市場區隔

第7章 市場特徵

  • 市場定義
  • 各用途市場區隔
    • 化療誘發性嗜中性白血球低下症
    • 移植
    • 其他
  • 各流通管道市場區隔
    • 醫院藥局
    • 零售藥局
    • 郵購/線上藥局

第8章 市場趨勢與策略

  • 為了促進生物相似藥醫藥品開發而修訂的FDA法規
  • 堅牢的研究開發
  • 多數的策略性聯盟
  • 成長的合併和收購

第9章 COVID-19的影響

  • COVID-19對主要市場企業的BioconBiologics的影響

第10章 市場規模與成長

  • 市場規模
  • 市場成長:銷售額成果(2015-2019)
    • 市場成長要素
    • 阻礙市場要素
  • 市場成長:銷售額預測(2019-2023,2025F,2030F)

第11章 市場區隔

  • 市場銷售額成果、預測:各用途(2015-2019,2023F,2025F,2030F)
    • 化療誘發性嗜中性白血球低下症
    • 移植
    • 其他
  • 市場銷售額成果、預測:各流通管道(2015-2019,2023F,2025F,2030F)
    • 醫院藥局
    • 零售藥局
    • 郵購藥局

第12章 市場分析:各地區/國家

  • 市場成果、預測:各區域銷售額(2015-2019,2023F,2025F,2030F)
  • 市場成果、預測:各國銷售額(2015-2019,2023F,2025F,2030F)

第13章 亞太地區市場

第14章 西歐市場

第15章 東歐市場

第16章 北美市場

第17章 南美市場

第18章 中東市場

第19章 非洲市場

第20章 競爭情形

  • 企業簡介
  • Coherus Biosciences Inc.
  • Biocon
  • Mylan
  • Sandoz (Novartis)

第21章 市場上主要合併和收購

第22章 市場機會及策略

  • 2023年的市場:提供最新機會的國家
  • 2023年的市場:提供最新機會的市場區隔
  • 2023年的市場:成長策略
    • 市場趨勢為基礎的策略
    • 競爭的策略

第23章 結論、建議

  • 結論
  • 建議

第24章 附錄

目錄

Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global pegfilgrastim biosimilars market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the pegfilgrastim biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global pegfilgrastim biosimilars market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by target antigen and by application.
  • Market Characteristics - The market characteristics section of the report defines and explains the pegfilgrastim biosimilars market. This chapter includes different services covered in the report and basic definitions.
  • Trends And Strategies - This chapter describes the major trends shaping the global pegfilgrastim biosimilars market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • COVID Impact Analysis - This section provides an insight on how the pandemic is impacting the pegfilgrastim biosimilars market.
  • Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2023F, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2019), forecast (2019-2023F, 2025F, 2030F) market value and growth and market share comparison by region.
  • Market Segmentation - This section contains the market values (2015-2019, 2019-2023F, 2025F, 2030F) and analysis for segment by type in the market.
  • Regional Market Size And Growth - This section contains the region's market size (2019), historic and forecast (2015-2019, and 2023F, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • Competitive Landscape - This section covers details on the competitive landscape of the global pegfilgrastim biosimilars market, estimated market shares and company profiles of the leading players.
  • Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for pegfilgrastim biosimilars companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global pegfilgrastim biosimilars market is segmented into -

By Application: Chemotherapy Induced Neutropenia; Transplantation; Others

By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail Order/ Online Pharmacies

Companies Mentioned: Coherus Biosciences Inc.; Biocon/Mylan; Sandoz

Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia.

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Pegfilgrastim Biosimilars Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Application
    • 6.1.3. Segmentation By Distribution Channel

7. Pegfilgrastim Biosimilars Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Application
    • 7.2.1. Chemotherapy Induced Neutropenia
    • 7.2.2. Transplantation
    • 7.2.3. Others
  • 7.3. Market Segmentation By Distribution Channel
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Mail Order/Online Pharmacies

8. Pegfilgrastim Biosimilars Market Trends And Strategies

  • 8.1. Revised FDA Regulations To Facilitate Biosimilar Drug Development
  • 8.2. Robust Research & Development
  • 8.3. Large Number Of Strategic Partnerships
  • 8.4. Growing Mergers And Acquisitions

9. Pegfilgrastim Biosimilars Market, COVID Impact Analysis

  • 9.1. Impact Of COVID-19 On Major Pegfilgrastim Biosimilar Market Player Biocon Biologics

10. Global Pegfilgrastim Biosimilars Market Size And Growth

  • 10.1. Market Size
  • 10.2. Historic Market Growth, 2015 - 2019, Value ($ Million)
    • 10.2.1. Drivers Of The Market 2015 - 2019
    • 10.2.2. Restraints Of The Market 2015-2019
  • 10.3. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
    • 10.3.1. Drivers Of The Market 2019 - 2023
    • 10.3.2. Restraints On The Market 2019 - 2023

11. Global Pegfilgrastim Biosimilars Market Segmentation

  • 11.1. Global Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 11.1.1. Chemotherapy induced neutropenia
    • 11.1.2. Transplantation
    • 11.1.3. Others
  • 11.2. Global Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 11.2.1. Hospital pharmacies
    • 11.2.2. Retail pharmacies
    • 11.2.3. Mail-Order pharmacies

12. Pegfilgrastim Biosimilars Market, Regional And Country Analysis

  • 12.1. Global Pegfilgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 12.2. Global Pegfilgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Pegfilgrastim Biosimilars Market

  • 13.1. Asia-Pacific Pegfilgrastim Biosimilars Market Overview
    • 13.1.1. Region Information
    • 13.1.2. Impact Of COVID-19
    • 13.1.3. Market Information
    • 13.1.4. Background Information
    • 13.1.5. Government Initiatives
    • 13.1.6. Regulations
    • 13.1.7. Regulatory Bodies
    • 13.1.8. Major Associations
    • 13.1.9. Taxes Levied
    • 13.1.10. Corporate Tax Structure
    • 13.1.11. Investments
    • 13.1.12. Major Companies
  • 13.2. Asia-Pacific Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.3. Asia-Pacific Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.4. Asia-Pacific Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.5. Asia-Pacific Pegfilgrastim Biosimilars Market: Country Analysis
  • 13.6. China Pegfilgrastim Biosimilars Market
  • 13.7. China Pegfilgrastim Biosimilars Market Overview
    • 13.7.1. Country Information
    • 13.7.2. Impact Of COVID-19
    • 13.7.3. Market Information
    • 13.7.4. Background Information
    • 13.7.5. Government Initiatives
    • 13.7.6. Regulations
    • 13.7.7. Regulatory Bodies
    • 13.7.8. Major Associations
    • 13.7.9. Taxes Levied
    • 13.7.10. Corporate Tax Structure
    • 13.7.11. Major Companies
  • 13.8. China Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.9. China Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.10. India Pegfilgrastim Biosimilars Market
  • 13.11. India Pegfilgrastim Biosimilars Market Overview
    • 13.11.1. Country Information
    • 13.11.2. Impact Of COVID-19
    • 13.11.3. Market Information
    • 13.11.4. Background Information
    • 13.11.5. Government Initiatives
    • 13.11.6. Regulations
    • 13.11.7. Regulatory Bodies
    • 13.11.8. Major Associations
    • 13.11.9. Taxes Levied
    • 13.11.10. Corporate Tax Structure
    • 13.11.11. Investments
    • 13.11.12. Major Companies
  • 13.12. India Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.13. India Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.14. Japan Pegfilgrastim Biosimilars Market
  • 13.15. Japan Pegfilgrastim Biosimilars Market Overview
    • 13.15.1. Country Information
    • 13.15.2. Impact Of COVID-19
    • 13.15.3. Market Information
    • 13.15.4. Background Information
    • 13.15.5. Government Initiatives
    • 13.15.6. Regulations
    • 13.15.7. Regulatory Bodies
    • 13.15.8. Major Associations
    • 13.15.9. Taxes Levied
    • 13.15.10. Corporate Tax Structure
    • 13.15.11. Major Companies
  • 13.16. Japan Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.17. Japan Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.18. Australia Pegfilgrastim Biosimilars Market
  • 13.19. Australia Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.20. Australia Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.21. Australia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.22. Indonesia Pegfilgrastim Biosimilars Market
  • 13.23. Indonesia Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.24. Indonesia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.25. South Korea Pegfilgrastim Biosimilars Market
  • 13.26. South Korea Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.27. South Korea Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.28. South Korea Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

14. Western Europe Pegfilgrastim Biosimilars Market

  • 14.1. Western Europe Pegfilgrastim Biosimilars Market Overview
    • 14.1.1. Region Information
    • 14.1.2. COVID Impact
    • 14.1.3. Market Information
    • 14.1.4. Background Information
    • 14.1.5. Government Initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investments
    • 14.1.12. Major Companies
  • 14.2. Western Europe Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.3. Western Europe Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.4. Western Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.5. Western Europe Pegfilgrastim Biosimilars Market: Country Analysis
  • 14.6. UK Pegfilgrastim Biosimilars Market
  • 14.7. UK Pegfilgrastim Biosimilars Market Overview
    • 14.7.1. Country Information
    • 14.7.2. COVID Impact
    • 14.7.3. Market Information
    • 14.7.4. Background Information
    • 14.7.5. Government Initiatives
    • 14.7.6. Regulations
    • 14.7.7. Regulatory Bodies
    • 14.7.8. Major Associations
    • 14.7.9. Taxes levied
    • 14.7.10. Corporate Tax Structure
    • 14.7.11. Investments
    • 14.7.12. Major Companies
  • 14.8. UK Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.9. UK Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.10. UK Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.11. Germany Pegfilgrastim Biosimilars Market
  • 14.12. Germany Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.13. Germany Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.14. Germany Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.15. France Pegfilgrastim Biosimilars Market
  • 14.16. France Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.17. France Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.18. France Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Pegfilgrastim Biosimilars Market

  • 15.1. Eastern Europe Pegfilgrastim Biosimilars Market Overview
    • 15.1.1. Region Information
    • 15.1.2. COVID Impact
    • 15.1.3. Market Information
    • 15.1.4. Background Information
    • 15.1.5. Government Initiatives
    • 15.1.6. Regulations
    • 15.1.7. Regulatory Bodies
    • 15.1.8. Major Associations
    • 15.1.9. Taxes levied
    • 15.1.10. Corporate Tax Structure
    • 15.1.11. Investments
    • 15.1.12. Major Companies
  • 15.2. Eastern Europe Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.3. Eastern Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.4. Eastern Europe Pegfilgrastim Biosimilars Market: Country Analysis
  • 15.5. Russia Pegfilgrastim Biosimilars Market
  • 15.6. Russia Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.7. Russia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

16. North America Pegfilgrastim Biosimilars Market

  • 16.1. North America Pegfilgrastim Biosimilars Market Overview
    • 16.1.1. Region Information
    • 16.1.2. Impact Of COVID-19
    • 16.1.3. Market Information
    • 16.1.4. Background Information
    • 16.1.5. Government Initiatives
    • 16.1.6. Regulations
    • 16.1.7. Regulatory Bodies
    • 16.1.8. Major Associations
    • 16.1.9. Taxes Levied
    • 16.1.10. Corporate Tax Structure
    • 16.1.11. Investments
    • 16.1.12. Major Companies
  • 16.2. North America Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 16.3. North America Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.4. North America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.5. North America Pegfilgrastim Biosimilars Market: Country Analysis
  • 16.6. USA Pegfilgrastim Biosimilars Market
  • 16.7. USA Pegfilgrastim Biosimilars Market Overview
    • 16.7.1. Country Information
    • 16.7.2. Impact Of COVID-19
    • 16.7.3. Market Information
    • 16.7.4. Background Information
    • 16.7.5. Government Initiatives
    • 16.7.6. Regulations
    • 16.7.7. Regulatory Bodies
    • 16.7.8. Major Associations
    • 16.7.9. Taxes Levied
    • 16.7.10. Corporate Tax Structure
    • 16.7.11. Investments
    • 16.7.12. Major Companies
  • 16.8. USA Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 16.9. USA Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.10. USA Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

17. South America Pegfilgrastim Biosimilars Market

  • 17.1. South America Pegfilgrastim Biosimilars Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Impact Of COVID-19
    • 17.1.3. Market Information
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Major Companies
  • 17.2. South America Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.3. South America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.4. South America Pegfilgrastim Biosimilars Market: Country Analysis
  • 17.5. Brazil Pegfilgrastim Biosimilars Market
  • 17.6. Brazil Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.7. Brazil Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

18. Middle East Pegfilgrastim Biosimilars Market

  • 18.1. Middle East Pegfilgrastim Biosimilars Market Overview
    • 18.1.1. Region Information
    • 18.1.2. COVID Impact
    • 18.1.3. Market Information
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Investments
    • 18.1.12. Major Companies
  • 18.2. Middle East Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.3. Middle East Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Africa Pegfilgrastim Biosimilars Market

  • 19.1. Africa Pegfilgrastim Biosimilars Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Impact Of COVID-19
    • 19.1.3. Market Information
    • 19.1.4. Background Information
    • 19.1.5. Government Initiatives
    • 19.1.6. Regulations
    • 19.1.7. Regulatory Bodies
    • 19.1.8. Major Associations
    • 19.1.9. Taxes Levied
    • 19.1.10. Corporate Tax Structure
    • 19.1.11. Major Companies
  • 19.2. Africa Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.3. Africa Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

20. Global Pegfilgrastim Biosimilars Market Competitive Landscape

  • 20.1. Company Profiles
  • 20.2. Coherus Biosciences Inc.
    • 20.2.1. Company Overview
    • 20.2.2. Products And Services
    • 20.2.3. Business Strategy
    • 20.2.4. Financial Overview
  • 20.3. Biocon
    • 20.3.1. Company Overview
    • 20.3.2. Products And Services
    • 20.3.3. Business Strategy
    • 20.3.4. Financial Overview
  • 20.4. Mylan
    • 20.4.1. Company Overview
    • 20.4.2. Products And Services
    • 20.4.3. Business Strategy
    • 20.4.4. Financial Overview
  • 20.5. Sandoz (Novartis)
    • 20.5.1. Company Overview
    • 20.5.2. Products And Services
    • 20.5.3. Business Strategy
    • 20.5.4. Financial Overview

21. Key Mergers And Acquisitions In The Pegfilgrastim Biosimilars Market

  • 21.1. Ligand Pharmaceuticals Acquired Pfenex
  • 21.2. True North Acquired Stake In Biocon Biologics
  • 21.3. Biocon Acquires Pfizer's R&D Facility To Boost Biosimilars Development
  • 21.4. Kashiv Pharma Acquired Adello Biologics
  • 21.5. Mundipharma International Limited Acquired Cinfa Biotech
  • 21.6. Biocon Merged With Sandoz
  • 21.7. Fresenius Kabi Acquired The Biosimilars Business Of Merck KGaA

22. Pegfilgrastim Biosimilars Market Opportunities And Strategies

  • 22.1. Global Pegfilgrastim Biosimilars Market In 2023 - Countries Offering Most New Opportunities
  • 22.2. Global Pegfilgrastim Biosimilars Market In 2023 - Segments Offering Most New Opportunities
  • 22.3. Global Pegfilgrastim Biosimilars Market In 2023 - Growth Strategies
    • 22.3.1. Market Trend Based Strategies
    • 22.3.2. Competitor Strategies

23. Pegfilgrastim Biosimilars Market, Conclusions And Recommendations

  • 23.1. Conclusions
  • 23.2. Recommendations
    • 23.2.1. Product
    • 23.2.2. Place
    • 23.2.3. Price
    • 23.2.4. Promotion
    • 23.2.5. People

24. Appendix

  • 24.1. Market Data Sources
  • 24.2. Research Methodology
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company
  • 24.6. Copyright and Disclaimer